Senior Manager, Commercial Finance and Accounting

We are seeking a  Senior Manager, Commercial Finance and Accounting who will report into the Senior Director, Financial Planning and Analysis. You will lead the finance and accounting functions critical to Celcuity’s commercial operations. This role is responsible for ensuring the accuracy and transparency of our revenue recognition, gross-to-net (GTN) estimates, revenue forecasting and related month-end close process.

• Lead the forecasting, budgeting, and long-range planning for GTN deductions, including rebates, chargebacks, distributor fees, and copay assistance programs.
• Partner directly with the Commercial and Market Access teams to develop and maintain GTN assumptions and forecasts, track performance, and evaluate pricing and contracting strategies.
• Analyze inventory trends and work cross-functionally to forecast inventory requirements, standard costs, and potential excess/obsolete (E&O) reserves.
• Perform monthly variance analysis for gross revenue, GTN deductions, and cost of goods sold (COGS), providing actionable insights to leadership.

• Own the month-end close processes for revenue and inventory, including oversight and review of third-party GTN calculations, validation of accrual estimates, preparation of related journal entries and account reconciliations.
• Maintain robust internal control procedures to mitigate financial reporting risks and ensure SOX compliance for commercial accounting cycles.
• Coordinate with external auditors on revenue recognition, GTN estimates, and inventory valuation to facilitate efficient quarterly reviews and annual audits.
• Drive improvements in financial systems, reporting tools and accounting processes to enhance operational efficiency and support scalable commercial operations.

• Collaborate closely with the Senior Director, Financial Planning & Analysis, and the Vice President, Accounting and Financial Reporting, on strategic initiatives, cross-functional projects and SEC reporting disclosures.
• Serve as the primary finance liaison for external commercial partners, including third-party logistics (3PLs) and specialty pharmacies, ensuring accurate data flow for accounting and forecasting.
• Other duties as assigned.

• Bachelor’s degree in accounting or finance; CPA or CMA preferred.
• Seven plus (7+) years of progressive finance and accounting experience, including at least two (2) years in a leadership role.
• Prior experience in a commercial-stage public biotechnology, pharmaceutical, or life sciences company is strongly preferred.
• Demonstrated expertise in ASC 606 revenue recognition, gross-to-net (GTN) accounting, and related forecasting processes.
• Strong background in financial planning and analysis, including revenue and inventory modeling.
• Experience strengthening accounting systems, processes, and internal controls in compliance with SOX, SEC, and U.S. GAAP requirements.
• Continuous improvement mindset; constantly seeking ways to drive innovation and efficiencies in financial operations.
• Outstanding organizational skills, attention to detail, and the ability to manage multiple complex processes and documentation requirements simultaneously.
• Exceptional leadership, communication, and cross-functional collaboration skills, with the ability to influence and build credibility across commercial, supply chain, and executive teams.
• Advanced analytical skills and high proficiency in Microsoft Excel, Word and PowerPoint, with experience in ERP systems commonly used in the life sciences industry.
• Maintain a positive, approachable and professional attitude.

Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to develop a better way to treat the cellular drivers of tumor growth.

Our lead therapeutic candidate, gedatolisib, is an intravenously administered, potential first-in-class PI3K/AKT/mTOR (PAM) pathway inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings. A Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is on-going.

Celcuity is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are competitive. For this role, the anticipated base pay range is $150,000 - $190,000. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience.

The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package. Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays.

Recruiters and staffing agencies should not contact Celcuity through this page. All recruitment vendors (search firms, recruitment agencies, and staffing companies) are prohibited from contacting our hiring manager(s), executive team members, or employees directly.

We require that all recruiters and staffing agencies have a fully executed, formal written agreement on file. Celcuity’s receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between Celcuity and such organization and will be considered unsolicited. Celcuity will not be responsible for related fees.